These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 8691344

  • 1. Decreased expression of galectin-3 is associated with progression of human breast cancer.
    Castronovo V, Van Den Brûle FA, Jackers P, Clausse N, Liu FT, Gillet C, Sobel ME.
    J Pathol; 1996 May; 179(1):43-8. PubMed ID: 8691344
    [Abstract] [Full Text] [Related]

  • 2. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
    Fernández PL, Merino MJ, Gómez M, Campo E, Medina T, Castronovo V, Sanjuán X, Cardesa A, Liu FT, Sobel ME.
    J Pathol; 1997 Jan; 181(1):80-6. PubMed ID: 9072007
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients.
    van den Brûle FA, Waltregny D, Castronovo V.
    J Pathol; 2001 Jan; 193(1):80-7. PubMed ID: 11169519
    [Abstract] [Full Text] [Related]

  • 5. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
    Wang L, Hoque A, Luo RZ, Yuan J, Lu Z, Nishimoto A, Liu J, Sahin AA, Lippman SM, Bast RC, Yu Y.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3660-6. PubMed ID: 14506155
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease.
    Kim TH, Huh JH, Lee S, Kang H, Kim GI, An HJ.
    Histopathology; 2008 Jul 01; 53(1):48-55. PubMed ID: 18479414
    [Abstract] [Full Text] [Related]

  • 7. Galectin-3, a laminin binding protein, fails to modulate adhesion of human melanoma cells to laminin.
    van den Brûle FA, Buicu C, Sobel ME, Liu FT, Castronovo V.
    Neoplasma; 1995 Jul 01; 42(5):215-9. PubMed ID: 8552198
    [Abstract] [Full Text] [Related]

  • 8. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes.
    Miyazaki J, Hokari R, Kato S, Tsuzuki Y, Kawaguchi A, Nagao S, Itoh K, Miura S.
    Oncol Rep; 2002 Jul 01; 9(6):1307-12. PubMed ID: 12375039
    [Abstract] [Full Text] [Related]

  • 9. The spectrum of 67-kD laminin receptor expression in breast carcinoma progression.
    Viacava P, Naccarato AG, Collecchi P, Ménard S, Castronovo V, Bevilacqua G.
    J Pathol; 1997 May 01; 182(1):36-44. PubMed ID: 9227340
    [Abstract] [Full Text] [Related]

  • 10. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
    Foster KW, Frost AR, McKie-Bell P, Lin CY, Engler JA, Grizzle WE, Ruppert JM.
    Cancer Res; 2000 Nov 15; 60(22):6488-95. PubMed ID: 11103818
    [Abstract] [Full Text] [Related]

  • 11. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation.
    Kawachi K, Matsushita Y, Yonezawa S, Nakano S, Shirao K, Natsugoe S, Sueyoshi K, Aikou T, Sato E.
    Hum Pathol; 2000 Apr 15; 31(4):428-33. PubMed ID: 10821488
    [Abstract] [Full Text] [Related]

  • 12. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P, Akram M, Benezra R, Brogi E.
    Hum Pathol; 2006 Aug 15; 37(8):1032-41. PubMed ID: 16867866
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
    Edwards DP, Grzyb KT, Dressler LG, Mansel RE, Zava DT, Sledge GW, McGuire WL.
    Cancer Res; 1986 Mar 15; 46(3):1306-17. PubMed ID: 3510721
    [Abstract] [Full Text] [Related]

  • 14. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
    Logullo AF, Lopes AB, Nonogaki S, Soares FA, Netto MM, Nishimoto IN, Brentani MM.
    Oncol Rep; 2007 Jul 15; 18(1):121-6. PubMed ID: 17549356
    [Abstract] [Full Text] [Related]

  • 15. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
    Moiseeva EV, Rapoport EM, Bovin NV, Miroshnikov AI, Chaadaeva AV, Krasilshschikova MS, Bojenko VK, Bijleveld C, van Dijk JE, Den Otter W.
    Breast Cancer Res Treat; 2005 Jun 15; 91(3):227-41. PubMed ID: 15952056
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
    Zheng WQ, Looi LM, Cheah PL.
    Pathology; 2001 Aug 15; 33(3):303-6. PubMed ID: 11523929
    [Abstract] [Full Text] [Related]

  • 17. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation.
    Plzák J, Smetana K, Hrdlicková E, Kodet R, Holíková Z, Liu FT, Dvoránkova B, Kaltner H, Betka J, Gabius HJ.
    Int J Oncol; 2001 Jul 15; 19(1):59-64. PubMed ID: 11408923
    [Abstract] [Full Text] [Related]

  • 18. BigH3 protein expression as a marker for breast cancer.
    Calaf GM, Echiburú-Chau C, Zhao YL, Hei TK.
    Int J Mol Med; 2008 May 15; 21(5):561-8. PubMed ID: 18425347
    [Abstract] [Full Text] [Related]

  • 19. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
    Sharma MR, Koltowski L, Ownbey RT, Tuszynski GP, Sharma MC.
    Exp Mol Pathol; 2006 Oct 15; 81(2):146-56. PubMed ID: 16643892
    [Abstract] [Full Text] [Related]

  • 20. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H, Stephens LC, Kumar R.
    Clin Cancer Res; 2006 Mar 01; 12(5):1479-86. PubMed ID: 16533771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.